Creatine plays a vital part in the energy metabolism and physiological roles. It is exclusively found in ingredients of animal origin, so using all‐plant protein‐based diets increases the risk of creatine deficiency. The objectives of this current study were to determine the optimal level of dietary guanidinoacetic acid (GAA) with regard to the nutrient digestibility, growth performance, feed utilization and carcass quality of Nile tilapia (Oreochromis niloticus). The fish (27.33 ± 0.70 g) were fed with five different isonitrogenous and isoenergetic diets for 60 days: T1 was the positive control diet (HF; 6% fish meal inclusion); T2 was the negative control formulated to contain no GAA (NC, free fish meal); and T3, T4 and T5 were NC supplemented with 0.06%, 0.12% and 0.18% of GAA respectively. At the end of the experiment, it was found that growth performance and feed utilization were not significantly different (p > .05) among the groups. However, fish from the T3 and T4 groups had slightly better weight gain and growth rate, as well as improved digestibility of protein, methionine, lysine and histidine (p < .05). Fish fed the dietary GAA at 0.06 or 0.12% had clearly larger width increment than the other groups. This is important as consumers prefer large dorsal muscles. This result from this study showed no adverse effect on haematological parameters, serum biochemistry parameters, fillet texture quality and histopathological change in the liver of Nile tilapia. Therefore, these results indicate that GAA supplementation at 0.06%–0.12% in Nile tilapia diet can potentially improve fish growth and feed utilization without setback on health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.